Press release
Advancements In Oral Androgen Deprivation Therapy For Advanced Prostate Cancer Trend: A Crucial Influence on the Gonadotropin-Releasing Hormone (GnRH) Agonist Market's Transformation in 2025
Gonadotropin-Releasing Hormone (GnRH) Agonist
The rise in hormone-related diseases is anticipated to drive the growth of the gonadotropin-releasing hormone (GnRH) agonist market. These disorders, caused by imbalances in the endocrine system, include conditions like diabetes, hyperthyroidism, and prostate cancer. Factors such as obesity, metabolic syndrome, genetics, and aging contribute to this rise. GnRH agonists help regulate hormone levels and provide targeted treatment for such conditions. For example, in December 2023, the Australian Bureau of Statistics reported that about 5.3% of Australians, or around 1.3 million people, lived with diabetes in 2022, with diabetes being the seventh leading cause of death in the country.
Get Your Gonadotropin-Releasing Hormone (GnRH) Agonist Market Report Here:
https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report
What Is the projected market size and growth rate for the gonadotropin-releasing hormone (gnrh) agonist market?
The gonadotropin-releasing hormone (GnRH) agonist market has experienced consistent growth in recent years. It is projected to grow from $4.1 billion in 2024 to $4.23 billion in 2025, with a compound annual growth rate (CAGR) of 3.2%. This growth is driven by rising awareness and diagnosis of hormonal disorders, an increasing incidence of hormone-related diseases, the rising prevalence of prostate cancer, growing awareness of hormone therapy, and a higher demand for long-term safety and effectiveness.
The gonadotropin-releasing hormone (GnRH) agonist market is projected to grow steadily, reaching $4.72 billion by 2029, with a compound annual growth rate (CAGR) of 2.8%. The growth is driven by increased awareness, early diagnosis, higher healthcare spending, expanded use in fertility treatments, personalized medicine demand, and greater research funding. Key trends include improvements in drug delivery systems, advances in oncology and reproductive medicine, a rising demand for hormone therapies, and the development of long-acting formulations.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18814&type=smp
What new trends are reshaping the gonadotropin-releasing hormone (gnrh) agonist market and its opportunities?
Companies in the gonadotropin-releasing hormone (GnRH) agonist market are developing advanced androgen deprivation therapy drugs to enhance the treatment of hormone-sensitive cancers. These therapies aim to lower or eliminate androgen levels to slow cancer progression. In January 2024, Zydus Lifesciences Limited launched Relugolix, branded as Rexigo, India's first once-daily oral therapy for testosterone suppression in advanced prostate cancer, providing a more convenient and affordable treatment compared to injectable alternatives.
What major market segments define the scope and growth of the gonadotropin-releasing hormone (gnrh) agonist market?
The gonadotropin-releasing hormone (GnRH) agonist market covered in this report is segmented -
1) By Type: Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types
2) By Formulation: Injectable, Implants, Oral, Nasal Sprays
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty, Fertility Treatment, Other Applications
5) By End-User: Hospital, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users
Subsegments:
1) By Leuprorelin: Injectable Leuprorelin, Implantable Leuprorelin
2) By Goserelin: Goserelin Injection, Goserelin Implant
3) By Taltirelin: Injectable Taltirelin, Oral Taltirelin
4) By Histrelin: Histrelin Implant, Histrelin Injection
5) By Other Type: Triptorelin, Buserelin, Nafarelin
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18814
Which region dominates the gonadotropin-releasing hormone (gnrh) agonist market?
North America was the largest region in the gonadotropin-releasing hormone (GnRH) agonist market in 2024. The regions covered in the gonadotropin-releasing hormone (GnRH) agonist market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the gonadotropin-releasing hormone (gnrh) agonist industry growth?
Major companies operating in the gonadotropin-releasing hormone (GnRH) agonist market are Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Sandoz Group AG, Ipsen Pharma, Aurobindo Pharma Limited, Cipla Limited, Dr Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Ferring Pharmaceuticals, Amneal Pharmaceuticals Inc., Endo International plc, Lupin Limited, Gland Pharma Limited, Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Limited, Bachem Holding AG, Tolmar Pharmaceuticals Inc., Debiopharm Group, Sun Pharmaceutical Industries Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18814&type=smp
What Is Covered In The Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report?
•Market Size Forecast: Examine the gonadotropin-releasing hormone (gnrh) agonist market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the gonadotropin-releasing hormone (gnrh) agonist market for a structured understanding.
•Key Players Overview: Analyze major players in the gonadotropin-releasing hormone (gnrh) agonist market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gonadotropin-releasing hormone (gnrh) agonist market.
•Segment Contributions: Evaluate how different segments drive overall growth in the gonadotropin-releasing hormone (gnrh) agonist market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gonadotropin-releasing hormone (gnrh) agonist market.
•Industry Challenges: Identify potential risks and obstacles affecting the gonadotropin-releasing hormone (gnrh) agonist market.
•Competitive Landscape: Review strategic developments in the gonadotropin-releasing hormone (gnrh) agonist market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advancements In Oral Androgen Deprivation Therapy For Advanced Prostate Cancer Trend: A Crucial Influence on the Gonadotropin-Releasing Hormone (GnRH) Agonist Market's Transformation in 2025 here
News-ID: 3925582 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for GnRH
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists Market to Record 8.5% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists Market Outlook: How is the Market Expected to Grow by 2025?
The market size of gonadotropin-releasing hormone (GnRH) receptor antagonists has experienced significant growth in recent times. Predictions indicate a rise from $1.46 billion in 2024 to $1.59 billion in 2025, with an 8.8% compound…
Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs Industry Gr …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs Market Size 2025?
The market for gonadotropin-releasing hormone (GnRH) agonists and antagonists drugs has seen considerable growth in recent past. The size of the market is expected to increase from $1.57 billion in 2024 to $1.73 billion…
Gonadotropin-Releasing Hormone (GnRH) Agonist Market Growth Accelerates: Strateg …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Gonadotropin-Releasing Hormone (GnRH) Agonist Industry Market Size Be by 2025?
The market size of the gonadotropin-releasing hormone (GnRH) agonist has been experiencing consistent growth in the last few years. It's projected to escalate from $4.1 billion in 2024 to $4.23 billion in 2025, with a compound…
GnRH Receptor Antagonists Market to Hit USD 1.2 billion in 2024, Highlighting St …
New Jersey, US State: "The global GnRH Receptor Antagonists market in the Healthcare and Pharmaceuticals category is projected to reach USD 2.5 billion by 2031, growing at a CAGR of 9.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 1.2 billion in 2024, highlighting strong growth potential throughout the forecast period."
GnRH Receptor Antagonists Market Size…
Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market to Reach $4.72 Billi …
What Is the Expected Size and Growth Rate of the Gonadotropin-Releasing Hormone (GnRH) Agonist Market?
There has been a consistent expansion in the market size of the gonadotropin-releasing hormone (GnRH) agonist in the past few years. The market is projected to rise from $4.1 billion in 2024 to $4.23 billion in 2025 with a compound annual growth rate (CAGR) of 3.2%. This surge during the historical period can be credited to…
GnRH Agonists & Antagonists Drugs for Endometriosis Market Rapid Growth: Size, F …
The GnRH Agonists & Antagonists Drugs for Endometriosis Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Get a Free Sample PDF - https://datamintelligence.com/download-sample/gnrh-agonists-and-antagonists-drugs-market
The Global GnRH agonists and antagonists drugs for…
